Static Chart Oncternal Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:30:00 05/06/2024 BST			5-day change	1st Jan Change
8.8 ^USD	+6.02%		-3.40%	-17.94%

05-30	Oncternal Announces Enrollment Completed and Dosing Initiated for Fifth Dose Cohort of Phase 1/2 Study of Onct-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer	CI
05-09	Transcript : Oncternal Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024

Duration

Period